Aktis Oncology is a biotechnology company pioneering the discovery and development of a new class of targeted radiopharmaceuticals for solid tumor cancers.
Location: United States, Massachusetts, Cambridge
Total raised: $156M
Investors 8
Funding Rounds 2
| Date | Series | Amount | Investors |
| 26.08.2022 | Series A | $84M | - |
| 22.03.2021 | Series A | $72M | - |
Mentions in press and media 12
| Date | Title | Description | Source |
| 26.08.2022 | Aktis Oncology Raises $84M in Series A Extension Funding | Aktis Oncology, a Cambridge, MA-based biotechnology company focused on advancing alpha radiopharmace... | finsmes.co... |
| 25.08.2022 | Aktis Oncology Inks $84M Series A Extension | CAMBRIDGE, MA, Aktis Oncology today announced it has raised a Series A Extension financing of $84 ... | vcnewsdail... |
| 25.08.2022 | Aktis Oncology Raises $84 Million To Advance Novel Targeted ... | - | bioimpactc... |
| 25.08.2022 | AKTIS ONCOLOGY RAISES $84 MILLION TO ADVANCE NOVEL TARGETED ... | - | mpmcapital... |
| 19.03.2021 | Aktis Oncology Announces $72M in Series A | CAMBRIDGE, MA, Aktis Oncology announced the completion of a $72 million Series A financing co-led ... | vcnewsdail... |
| 19.03.2021 | Aktis Oncology launches with $72M | Biotech startup Aktis Oncology has secured $72 million in Series A financing. The company was founde... | pitchbook.... |
| 18.03.2021 | Aktis Oncology Announces $72M Series A Financing To Advance ... | - | vidaventur... |
| 18.03.2021 | Aktis Oncology Announces $72M Series A Financing To Advance ... | CAMBRIDGE, Mass., March 18, 2021 /PRNewswire/ -- Aktis Oncology, a biotechnology company discoveri... | prnewswire... |
| 18.03.2021 | Aktis Oncology Raises $72M in Series A Financing | Aktis Oncology, a Cambridge, Mass.-based biotechnology company discovering and developing a novel cl... | finsmes.co... |
| 18.03.2021 | Aktis Oncology Announces $72 Million Series A Financing to A... | - | tcgcrossov... |
Show more